Zacks.com on MSN6d
MDT Stock Might Gain From Expanded AiBLE Ecosystem and New Partnership
Medtronic expands AiBLE spine surgery ecosystem with new technologies and a partnership with Siemens Healthineers.
Medtronic’s Buy Rating Justified by Growth in CST Sector and AiBLE’s Market Integration
Analyst Josh Jennings from TD Cowen maintained a Buy rating on Medtronic (MDT – Research Report) and keeping the price target at $95.00.
Medtronic expands AiBLE™ spine surgery ecosystem with new technologies and Siemens Healthineers partnership
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced today at the North American Spine Society (NASS) 39th Annual Meeting in Chicago the commercial launch of several software ...
Nasdaq6d
MDT Stock Might Gain From Expanded AiBLE Ecosystem and New Partnership
At the North American Spine Society’s 39th Annual Meeting in Chicago, Medtronic plc MDT commercially launched several software, hardware and imaging innovations to advance its AiBLE spine ...
Morningstar7d
Medtronic expands AiBLE™ spine surgery ecosystem with new technologies and Siemens Healthineers partnership
These enhancements are designed to advance AiBLE™, the Medtronic smart ecosystem of innovative navigation, robotics, data and AI, imaging, software and implants that enable more predictable ...
MassDevice7d
Medtronic, Siemens Healthineers partner to expand spine surgery ecosystem
Medtronic (NYSE: MDT) announced the commercial launch of several software, hardware and imaging offerings for spine and ...
FierceBiotech6d
Medtronic, Siemens Healthineers team up on spine surgery imaging
Two of the top 10 largest medtech companies will partner together on robotic head and spine procedures, with Medtronic ...